Nociceptor–Macrophage Interactions in Apical Periodontitis

Version	Summary	Created by	Modification	Content Size	Created at	Operation
1		Nandita Menon	--	2994	2023-09-13 20:30:11	\|
2	Reference format revised.	Lindsay Dong	Meta information modification	2994	2023-09-15 03:03:05	\|

This entry is adapted from the peer-reviewed paper 10.3390/biom13081193

Periradicular tissues have a rich supply of peripheral afferent neurons, also known as nociceptive neurons, originating from the trigeminal nerve. While their primary function is to relay pain signals to the brain, these are known to be involved in modulating innate and adaptive immunity by initiating neurogenic inflammation (NI).

nociceptors macrophages neuropeptides pain cytokines apical periodontitis

1. Introduction

Apical periodontitis (AP) is an inflammatory disease of periradicular tissue caused by oral opportunistic bacteria and their toxins retained in the apical regions of the periodontium ^[1]^[2]. Rich in blood vessels and nerve fibers, the periradicular tissue is composed of fibroblasts, epithelial cells, odontoblasts, cementoblasts, osteoblasts, osteoclasts, macrophages, and undifferentiated stem cells that form the periodontal ligament (PDL) and alveolar bone ^[3]^[4]. An infected root canal system in the apical periodontium causes all these immune cells and precursor cells to interact with one another, thereby eliciting an immune response against pathogens and pathogen-associated molecular patterns (PAMPs) ^[5]. However, AP can persist asymptomatically, without common clinical symptoms such as pain and swelling, while afferent sensory neurons that typically relay pain continue to engage in immune responses at the molecular level ^[6]^[7].

Neurogenic inflammation (NI) is set in motion when neuropeptides such as Substance P (SP) and Calcitonin Gene-Related Peptide (CGRP), among others, released by activated nociceptors act on resident immune cells and endothelial cells, causing vascular changes resulting in an influx of migrating immune cells to an inflamed tissue. To facilitate their function in NI, endothelial cells (vascular cells), mast cells, dendritic cells, T and B lymphocytes, and macrophages express cell-surface receptors for neuropeptides released by nociceptors ^[8]^[9]. Neuropeptides activate immune cells which release proinflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, nerve growth factor (NGF), and prostaglandin E2 (PGE2) that are in turn known to activate sensory neurons ^[10]^[11]. Neuropeptides also play a role in regulating anti-inflammatory roles of immune cells. For example, CGRP has been shown to inhibit the production of pro-inflammatory cytokines and enhance the expression of a regulatory phenotype in activated macrophages ^[12]. This reflects on the pleiotropic nature of neuropeptides that are capable of modulating immune response.

2. Macrophages in Apical Periodontitis

Inflammation is the physiological response to injury, stress, or infection. In terms of the immune cells involved, inflammation is the state in which innate and adaptive cells are activated, undergo differentiation, and migrate to resolve inflammation while restoring tissue homeostasis. A rapid host immune response is capable of resolving acute inflammation. On the other hand, prolonged exposure to triggers such as damage-associated molecular patterns (DAMPs), PAMPS, and pathogens results in a state of chronic inflammation that sees different immune and non-immune cells in action ^[13].

Acute AP is marked by the presence of periapical abscesses, while periapical granulomas are typically a sign of chronic AP, typically diagnosed via the radiographic visualization of rarefying osteitis in periapical tissues. AP is dynamic in nature because of the different immune cell types participating in different stages of AP. This dynamic nature can be observed via the progressive change in the distribution of immune cells in the periapical inflammatory infiltrate ^[14]^[15]. Immune cells can also undergo polarization to different phenotypes in order to facilitate the host immune response in disease or wound-healing ^[16]^[17].

Physiologically, the PDL has a key role in responding to microbes located within the pulp space. The PDL is a highly vascularized tissue, with up to ten times higher vascular volume than other fibrous connective tissues ^[18]. The blood vessels in PDL primarily participate in tooth support and shock absorption ^[19]. The activation of immune cells such as macrophages leads to the release of proinflammatory cytokines that increase the expression of cellular adhesion molecule (CAM-1) in endothelial cells, thereby promoting the local adhesion of monocytes and leukocytes ^[16]^[20]. This local response, combined with vasodilation caused by initial inflammation response, leads to the active infiltration of monocytes to the site of inflammation, where growth factors, pro-inflammatory cytokines, and microbial products induce cellular differentiation ^[21]^[22]. Once at the site of inflammation, these circulatory monocytes can be differentiated into macrophages or dendritic cells ^[23].

Toll-like receptor-4 (TLR4) is a sensory receptor predominantly expressed by human myeloid cells (monocytes and granulocytes) that recognize PAMPs such as lipopolysaccharides (LPS) expressed by Gram-negative bacteria ^[24]. Activated TLR4 recruits adaptor proteins that undergo phosphorylation. Myeloid differentiation primary response 88 (MyD88), Interleukin-1 receptor-associated kinase (IRAK), and tumor necrosis factor receptor-associated factor-6 (TRAF-6) are examples of such adaptor proteins. Phosphorylated adaptor proteins activate Nuclear Factor kappa B (NFκB) and mitogen-activated protein kinase (MAPK) signaling pathways, resulting in the expression of pro-inflammatory cytokines ^[25].

Macrophages are known to play an active role in resolving inflammation ^[26]. Activated macrophages can polarize into functional phenotypes of classically activated M1, or alternatively activated M2, to bring about pro- and anti-inflammatory effects, respectively. M1 macrophages produce pro-inflammatory cytokines TNF-α, IL-1β, and IL-6, which stimulate the production of tissue-damaging proteases and prostaglandins while mediating bone resorption. M1 macrophages also produce chemokines such as C-X-C motif chemokine ligand (CXCL)9 and CXCL10 that attract members of the adaptive immunity to the site of inflammation ^[27]^[28]. M2 macrophages are known to produce anti-inflammatory cytokines Transforming Growth Factor (TGF)-β and IL-10, which downregulate inflammation and immune response ^[29]^[30]. Their phagocytic capabilities help clear apoptotic cells and debris in healing tissues ^[5]^[31].

3. Role of Macrophages in Alveolar Bone Resorption

Resident macrophages in periodontal tissues secrete inflammatory cytokines and chemokines in response to pathogens. Qualitative and quantitative analyses have identified macrophages as the major constituent immune cell type in periapical granulomas ^[32]. This can be partly attributed to the vasodilation caused by the initial immune response, which in turn leads to the active infiltration of monocytes to the site of inflammation, wherein the growth factors, pro-inflammatory cytokines, and microbial products would induce differentiation to macrophages ^[22]^[33].

Alveolar bone resorption (loss) is a notable radiographic indication of chronic AP. The alveolar bone functions to hold teeth in the socket while absorbing any force applied to the teeth during biting and chewing. Subject to varying degrees of mechanical forces, the alveolar bone undergoes repeating cycles of bone formation and resorption. In a state of proinflammation, this equilibrium tends towards bone resorption, resulting in the loss of both mineral and organic components of the alveolar bone. The close association of macrophages with different stages of AP implicates these cells in the development of alveolar bone resorption. Macrophages were observed near osteoblasts in rat models of AP during the initial stages of bone resorption, while no macrophages were seen near the surfaces undergoing bone formation ^[17].

Osteoclastogenesis, or the development of mature osteoclasts (bone resorptive cells) from precursor cells, is mediated by receptor activator of nuclear factor kappa-β ligand (RANKL) ^[34]. RANKL is a cytokine produced by osteoblasts (which synthesize bone matrix and differentiate into osteocytes ^[35]) and stromal cells that binds to its receptor, RANK, to initiate the differentiation of osteoclast precursor cells ^[36]. This process is regulated by Osteoprotegerin (OPG), a decoy receptor of RANKL that is primarily produced by osteoblasts ^[37]. Hence, the RANKL-RANK-OPG trio are the main players in bone modeling and remodeling pathways ^[38]. GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) is a cytokine that induces proliferation and maturation in macrophages, and it has been found to promote fusion of prefusion osteoclasts in the presence of RANKL, enabling bone resorption under pathologic and inflammatory conditions ^[39]^[40].

4. Sensory Neuronal Activation in Apical Periodontitis

Periradicular tissues have an abundant supply of neurons that originate in the trigeminal ganglion (TG) ^[41]. Research groups in the 1970s identified nociceptive afferents with different activation thresholds and conduction velocities in the PDL ^[42]. Immunocytochemical analysis identified NGF-positive sensory nerves in periodontal tissues from rats ^[43], while ultrastructural analyses of the human PDL using electron microscopy identified Ruffini nerve endings, free nerve endings, and lamellated corpuscles ^[44]. Electrophysiological studies performed on cat models helped characterize trigeminal nerve endings in the PDL into low-threshold mechanoreceptors sensitive to mechanical load and vibration (A-β fibers) and nociceptors sensitive to pressure, temperature, and chemical irritants (A-δ, C-fibers) ^[45]^[46]. A-β fibers have large cell bodies, and these are myelinated ^[47]^[48]. A-δ fibers have medium-sized cell bodies, and C-fibers are considered the smallest ^[47]^[48]^[49]. Myelinated A-δ fibers have higher conduction velocities, resulting in a sharp pain sensation compared to the unmyelinated, slow C-fibers, which relay a delayed and dull, ache-like pain ^[47]^[50].

Specialized surface receptors expressed by nociceptors play a crucial role in the cascade of events that led to NI (Figure 1). Transient receptor potential (TRP) channels are a class of integral membrane proteins that function as signal transducers in sensory neurons. These are polymodal in nature and can be activated by intracellular and/or extracellular mechanical, thermal, chemical, and osmotic pressure gradients. Based on sequence similarity, several classes of TRP channels exist. The TRPV subfamily (vanilloid subtype) has six members, of which TRPV1 has garnered attention for its role in the detection of noxious physical and chemical stimuli ^[51]^[52]. TRPA1 is the sole member of the TRPA subfamily (ankyrin subtype) ^[53]^[54]. The detailed 3D structure of the TRPA1 receptor was previously characterized by Cao et al. and Liao et al. ^[55]^[56].

Figure 1. Nociceptor neurons express receptor molecules that recognize PAMPs, DAMPs, cytokines, and neuropeptides. This results in the activation of downstream signaling pathways that can contribute to neurogenic inflammation.

Toll-like receptors (TLRs) are another class of surface receptors that have been identified on nociceptors. The nociceptor expression of TLR4 highlights its role in the host immune response to bacterial infections ^[57]^[58]. Peripheral sensory neurons showed the colocalized expression of TLR4 and CD14, indicating the capability of the direct detection of PAMPs ^[58]. Besides immunological implications, the LPS binding of TLR4 on trigeminal neurons was shown to increase sensitization of TRPV1 channels, leading to increased expression of CGRP, which suggests a possible mechanism for pain associated with bacterial infections ^[59]^[60]^[61].

5. Role of Sensory Neuropeptides in Pain and Inflammation

CGRP was discovered in 1982 by Amara et al. ^[62]. This 37-residue peptide was found to be expressed in the central and peripheral nervous systems, promoting sensory, motor, and autonomic functions in the brain ^[63]. CGRP has two isoforms, α-CGRP and β-CGRP, which have over 90% similar homology and share similar biological effects in humans ^[64]. CALC I gene undergoes alternate splicing to generate α-CGRP, while β-CGRP is a product of CALC II gene transcription. While α-CGRP is predominant in the central and peripheral nervous systems, β-CGRP is found mainly in the enteric nervous system ^[64].

The CGRP receptor molecule is a G protein-coupled receptor and is composed of three components: receptor activity modifying protein 1 (RAMP1), Calcitonin-like receptor (CLR), and receptor component protein (RCP). All three components are required to form a fully functional CGRP receptor (CGRP-R). Upon activation by binding with CGRP, CGRP-R may couple with G protein α subunit, increasing the cyclical adenosine monophosphate (cAMP) levels, which activate protein kinase A (PKA).

Substance P (SP) is an undecapeptide that was first discovered in 1931 by Von Euler and Gaddum ^[65]. SP, neurokinin A (NKA), neuropeptide K (NPK), and neuropeptide γ (NPγ) are tachykinin neuropeptides encoded by the TAC1 gene; alternate RNA splicing and differential post-translational processing result in the expression of specific tachykinin peptides ^[66]. SP is best known for its role as a modulator of pain perception by altering cellular signaling pathways using G protein-coupled receptors called neurokinin 1 receptor (NK-1R) that can act through the cAMP secondary messenger system or inositol triphosphate (IP3)-diacylglycerol (DAG) system ^[67].

CGRP and SP are known to colocalize, and these have been studied to assess the degree of pain experienced by patients with symptomatic AP ^[68]. Affirming their role in oral diseases, several studies have reported increased levels of CGRP and SP in the sites of inflammation in the dental pulp ^[69]^[70], periodontal ligament ^[71]^[72], and saliva and gingival crevicular fluid ^[73]^[74]^[75]. The levels of neuropeptides in these environments are correlated with the degrees of inflammation, confirming their role in inflammatory mechanisms ^[70]^[73]^[76].

CGRP and SP play vital roles in modulating bone resorption. In murine AP models, TRPV1-positive sensory neurons were shown to regulate osteoclastogenesis via CGRP signaling ^[77].

SP and CGRP have also been shown to mediate tissue repair. The sprouting of CGRP-positive fibers in odontoblast layers after injury induced in the cervical dentin of rats resulted in the formation of reparative dentin ^[78]. SP released by stimulated peripheral nerves increased blood flow to the dental pulp, thereby enabling tissue healing ^[76]^[79]. Hence, SP and CGRP can be considered immunomodulators that can have pro- and anti-inflammatory effects depending on molecular cues present in the tissue microenvironment.

6. Neuro-Immune Interactions Modulate Inflammation and Healing in AP

Evidence of a functional link between sensory neurons and immune cells comes from the proximity of sensory nerve endings and immune cells. This is corroborated by the expression of neuropeptide-specific receptors on immune cells and cytokine receptors and receptors capable of recognizing microbial pathogens on trigeminal nociceptor neurons ^[8]^[80] (Figure 1 and Figure 2).

Figure 2. In addition to releasing neuropeptides, macrophages have been shown to express neuropeptide-specific receptors, indicating a significant role in neuro-immune cross-talk.

In vitro studies have confirmed the expression of CGRP-R and NK-1R in murine and human macrophages, implying that neuropeptides CGRP and SP influence the activities of these immune cells ^[81]^[82]. Pro-inflammatory cytokines IL-1, IL-4, and interferon (IFN)-γ were also shown to induce NK-1R expression in macrophages ^[83]^[84]. Goldman et al. were among the first to conduct in vitro studies on peritoneal macrophages, showing enhanced phagocytosis when exogenous SP was applied to these cells ^[85]. The SP-mediated activation of macrophages was discovered when exposure to SP increased levels of eicosanoids in macrophages ^[86]. SP also acts as a chemoattractant for monocytes and macrophages, first demonstrated in vitro using human monocytes and peritoneal macrophages from guinea pigs ^[87]^[88]. Evidence of TNF-α, IL-1, and IL-6 release in macrophages in response to SP was also previously recorded ^[89].

Early identification of CGRP immunoreactive (CGRP-IR) nerve fibers in the PDL led to increased interest in studying their response to different stimuli. Dynamic changes were observed in CGRP-IR nerve densities surrounding blood vessels in PDL during tooth movement in rat molars ^[90]. Wakisaka et al. were among the first to study the distribution of SP-positive nerve fibers in rat PDL ^[91]. However, when immunoreactions for CGRP, SP, and neuropeptide Y (NPY) were evaluated in dental pulp, periodontal ligament, and gingiva in cats, denser innervation in the pulp was reported, and these nerves were found to be more immunoreactive to CGRP than to SP ^[92].

Dynamic changes in the distribution of sensory nerves during acute and chronic AP have drawn attention to understanding how these specialized neurons may modulate disease progression. Several studies measured increased levels of neuropeptides in saliva and gingival crevicular fluid (GCF) in animal models and in patients diagnosed with AP ^[93]^[94]. Similarly, investigations on the distribution patterns of neuropeptides in periodontitis suggested the potential of using neuropeptides as biomarkers for the early detection of periodontitis ^[95]^[96].

Macrophages express functional CGRP-R, i.e., receptors of CGRP. CGRP activation led to the proliferation and differentiation of murine macrophages into osteoclast-like cells via a cAMP/PKA-dependent signaling pathway ^[97]. Murine bone-marrow-derived macrophages (BMDMs) showed increased IL-6 expression as a response to CGRP activation, which led to speculations about the role of BMDMs in the negative inhibition of B cell development ^[98]. Similar findings were reported in rat models that demonstrated reduced IL-6 expression in invading macrophages upon perineural injection of a CGRP antagonist ^[99].

Primarily produced by sensory neurons in the periodontal tissues, NGF is a neurotrophic factor that plays a critical role in neurogenesis, promoting the growth, differentiation, and survival of neurons ^[100]^[101]. Nerve Growth Factor-Tropomyosin receptor kinase A (NGF/TrkA) signaling suppresses CGRP production in monocytes as well as RAW264.7 macrophages ^[81]. In periodontal tissues that have a rich sensory nerve supply, NGF can induce increased neural sprouting and innervation under inflammation. NGF also controls the expression and release of neuropeptides in sensory neurons. NGF-mediated neural responses have direct implications on the host tissue response to inflammation ^[102]^[103]. NGF has been shown to induce monocyte differentiation in macrophages, thereby enhancing inflammatory effects ^[104].

SP was found to bind NK-1R receptors on murine macrophages and activate protein kinase C (PKC) or phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt), which triggers nuclear factor kappa-light-chain-enhancer of activated B cells transactivation and chemokine response via ERK1/2 and p38 MAPK signaling pathways ^[105]^[106]. Both resulted in the expression of the chemokines macrophage inflammatory protein-2 (MIP-2) and MCP-1. MIP-2 is a potent chemoattractant for neutrophils, and MCP-1 regulates monocyte migration and infiltration ^[107]^[108]. Macrophages produce SP in response to NF-κB activation, linking this phenomenon with the pro-inflammatory M1 macrophage phenotype. The administration of exogenous SP has been found to increase IL-10 expression in rat models, creating conducive environment for the activation of anti-inflammatory M2 macrophages, which can also produce SP ^[109]^[110].

7. Association of Pain with Nociceptor-Macrophage Cross-talk in AP

Pain is a natural response to tissue damage, and current investigations highlight a close association of this sensation with nociceptor–immune-cell interactions ^[111]. Several aspects can contribute to the presentation of pain in endodontic infections, including the volume of root canal space, the presence of pathogen diversity, the virulence of pathogenic load, the state of the immune system in an individual, and lesion dynamics, among others ^[112]. Despite standardized systems such as Numeric Rating Scale (NRS-11) and periapical index (PAI), which can correlate pain with clinical presentations in AP, these cannot be used to predict when and why pain is not experienced by patients with chronic AP ^[113]^[114].

Immune cells modulate nociceptor activity using cytokines and chemokines, and nociceptors in turn modulate functions of immune cells by expressing neuropeptides, resulting in a dynamic, bi-directional cross-talk between these two cell entities during tissue injury and inflammation ^[115] (Figure 3). Nociceptors express receptor molecules that are activated by PAMPs, DAMPs, and mediators released by immune cells. Neutrophils, mast cells, and macrophages have close encounters with nociceptive nerve terminals, and hence, mediators produced by these immune cells can induce pain sensitization and influence chronicity of pain. Macrophages produce TNF-α, IL-1β, IL-6, PGE2, and Leukotriene B4 (LTB4), covering a range of cytokines, growth factors, and lipids that bind to specific receptors on nociceptor neurons and result in direct pain sensitization or engage ion channels to increase neuronal cell excitation which then causes pain sensitization ^[111]. Such pain sensitization translates to hyperalgesia or allodynia in AP.

Figure 3. Bi-directional cross-talk between nociceptor neurons and macrophages has been implicated in inflammation, resulting in pain and bone resorption in apical periodontitis.

References

Nair, P.N.R. On the causes of persistent apical periodontitis: A review. Int. Endod. J. 2006, 39, 249–281.
Korona-Glowniak, I.; Piatek, D.; Fornal, E.; Lukowiak, A.; Gerasymchuk, Y.; Kedziora, A.; Bugla-Płoskonska, G.; Grywalska, E.; Bachanek, T.; Malm, A. Patterns of Oral Microbiota in Patients with Apical Periodontitis. J. Clin. Med. 2021, 10, 2707.
Hassell, M.T. Tissues and cells of the periodontium. Periodontology 2000 1993, 3, 9–38.
Nanci, A.; Bosshardt, D.D. Structure of periodontal tissues in health and disease*. Periodontology 2000 2006, 40, 11–28.
Hussein, H.; Kishen, A. Local Immunomodulatory Effects of Intracanal Medications in Apical Periodontitis. J. Endod. 2022, 48, 430–456.
Jonasson, P.; Kvist, T. Diagnosis of apical periodontitis in root-filled teeth. Clin. Dent. Rev. 2018, 2, 15.
Li, F.-C.; Kishen, A. 3D Organoids for Regenerative Endodontics. Biomolecules 2023, 13, 900.
Chiu, I.M.; von Hehn, C.A.; Woolf, C.J. Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology. Nat. Neurosci. 2012, 15, 1063–1067.
Assas, B.M.; Pennock, J.I.; Miyan, J.A. Calcitonin gene-related peptide is a key neurotransmitter in the neuro-immune axis. Front. Neurosci. 2014, 8, 23.
Kabata, H.; Artis, D. Neuro-immune crosstalk and allergic inflammation. J. Clin. Investig. 2019, 129, 1475–1482.
Crosson, T.; Roversi, K.; Balood, M.; Othman, R.; Ahmadi, M.; Wang, J.-C.; Seadi Pereira, P.J.; Tabatabaei, M.; Couture, R.; Eichwald, T.; et al. Profiling of how nociceptor neurons detect danger—New and old foes. J. Intern. Med. 2019, 286, 268–289.
Baliu-Piqué, M.; Jusek, G.; Holzmann, B. Neuroimmunological communication via CGRP promotes the development of a regulatory phenotype in TLR4-stimulated macrophages. Eur. J. Immunol. 2014, 44, 3708–3716.
Zehnder, M.; Belibasakis, G.N. On the dynamics of root canal infections—What we understand and what we don′t. Virulence 2015, 6, 216–222.
Azeredo, S.V.; Brasil, S.C.; Antunes, H.; Marques, F.V.; Pires, F.R.; Armada, L. Distribution of macrophages and plasma cells in apical periodontitis and their relationship with clinical and image data. J. Clin. 2017, 9, e1060–e1065.
Márton, I.J.; Kiss, C. Overlapping Protective and Destructive Regulatory Pathways in Apical Periodontitis. J. Endod. 2014, 40, 155–163.
Nair, P.N.R. Pathogenesis of Apical Periodontitis and the Causes of Endodontic Failures. Crit. Rev. Oral Biol. Med. 2004, 15, 348–381.
Akamine, A.; Anan, H.; Hamachi, T.; Maeda, K. A histochemical study of the behavior of macrophages during experimental apical periodontitis in rats. J. Endod. 1994, 20, 474–478.
Sims, M.R. A model of the anisotropic distribution of microvascular volume in the periodontal ligament of the mouse mandibular molar. Aust. Orthod. J. 1987, 10, 21–24.
Masset, A.; Staszyk, C.; Gasse, H. The blood vessel system in the periodontal ligament of the equine cheek teeth—Part II: The micro-architecture and its functional implications in a constantly remodelling system. Ann. Anat. Anat. Anz. 2006, 188, 535–539.
Graunaite, I.; Lodiene, G.; Maciulskiene, V. Pathogenesis of apical periodontitis: A literature review. J. Oral Maxillofac. Res. 2012, 2, e1.
Cekici, A.; Kantarci, A.; Hasturk, H.; Van Dyke, T.E. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontology 2000 2014, 64, 57–80.
Davies, L.C.; Jenkins, S.J.; Allen, J.E.; Taylor, P.R. Tissue-resident macrophages. Nat. Immunol. 2013, 14, 986–995.
Yang, J.; Zhang, L.; Yu, C.; Yang, X.-F.; Wang, H. Monocyte and macrophage differentiation: Circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark. Res. 2014, 2, 1.
Molteni, M.; Gemma, S.; Rossetti, C. The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation. Mediat. Inflamm. 2016, 2016, 6978936.
Rayees, S.; Rochford, I.; Joshi, J.C.; Joshi, B.; Banerjee, S.; Mehta, D. Macrophage TLR4 and PAR2 Signaling: Role in Regulating Vascular Inflammatory Injury and Repair. Front. Immunol. 2020, 11, 2091.
Garlet, G.P.; Giannobile, W.V. Macrophages: The Bridge between Inflammation Resolution and Tissue Repair? J. Dent. Res. 2018, 97, 1079–1081.
House, I.G.; Savas, P.; Lai, J.; Chen, A.X.Y.; Oliver, A.J.; Teo, Z.L.; Todd, K.L.; Henderson, M.A.; Giuffrida, L.; Petley, E.V.; et al. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade. Clin. Cancer Res. 2020, 26, 487–504.
Yao, Y.; Cai, X.; Ren, F.; Ye, Y.; Wang, F.; Zheng, C.; Qian, Y.; Zhang, M. The Macrophage-Osteoclast Axis in Osteoimmunity and Osteo-Related Diseases. Front. Immunol. 2021, 12, 664871.
Italiani, P.; Boraschi, D. From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation. Front. Immunol. 2014, 5, 514.
Lappin, D.F.; Macleod, C.P.; Kerr, A.; Mitchell, T.J.; Kinane, D.F. Anti-inflammatory cytokine IL-10 and T cell cytokine profile in periodontitis granulation tissue. Clin. Exp. Immunol. 2001, 123, 294–300.
Zhu, L.; Hua, F.; Ding, W.; Ding, K.; Zhang, Y.; Xu, C. The correlation between the Th17/Treg cell balance and bone health. Immun. Ageing 2020, 17, 30.
Stern, M.H.; Dreizen, S.; Mackler, B.F.; Selbst, A.G.; Levy, B.M. Quantitative analysis of cellular composition of human periapical granuloma. J. Endod. 1981, 7, 117–122.
Shapouri-Moghaddam, A.; Mohammadian, S.; Vazini, H.; Taghadosi, M.; Esmaeili, S.-A.; Mardani, F.; Seifi, B.; Mohammadi, A.; Afshari, J.T.; Sahebkar, A. Macrophage plasticity, polarization, and function in health and disease. J. Cell. Physiol. 2018, 233, 6425–6440.
Kawai, T.; Matsuyama, T.; Hosokawa, Y.; Makihira, S.; Seki, M.; Karimbux, N.Y.; Goncalves, R.B.; Valverde, P.; Dibart, S.; Li, Y.-P.; et al. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am. J. Pathol. 2006, 169, 987–998.
Dallas, S.L.; Bonewald, L.F. Dynamics of the transition from osteoblast to osteocyte. Ann. N. Y. Acad. Sci. 2010, 1192, 437–443.
Pérez-Sayáns, M.; Somoza-Martín, J.M.; Barros-Angueira, F.; Rey, J.M.G.; García-García, A. RANK/RANKL/OPG role in distraction osteogenesis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2010, 109, 679–686.
Wada, T.; Nakashima, T.; Hiroshi, N.; Penninger, J.M. RANKL–RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 2006, 12, 17–25.
Boyce, B.F.; Xing, L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch. Biochem. Biophys. 2008, 473, 139–146.
Ushach, I.; Zlotnik, A. Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage. J. Leukoc. Biol. 2016, 100, 481–489.
Lee, M.S.; Kim, H.S.; Yeon, J.-T.; Choi, S.-W.; Chun, C.H.; Kwak, H.B.; Oh, J. GM-CSF Regulates Fusion of Mononuclear Osteoclasts into Bone-Resorbing Osteoclasts by Activating the Ras/ERK Pathway1. J. Immunol. 2009, 183, 3390–3399.
Willis, R.D.; DiCosimo, C.J. The absence of proprioceptive nerve endings in the human periodontal ligament: The role of periodontal mechanoreceptors in the reflex control of mastication. Oral Surg. Oral Med. Oral Pathol. 1979, 48, 108–115.
Byers, M.R. Sensory innervation of periodontal ligament of rat molars consists of unencapsulated Ruffini-like mechanoreceptors and free nerve endings. J. Comp. Neurol. 1985, 231, 500–518.
Byers, M.R. Segregation of NGF receptor in sensory receptors, nerves and local cells of teeth and periodontium demonstrated by EM immunocytochemistry. J. Neurocytol. 1990, 19, 765–775.
Lambrichts, I.; Creemers, J.; van Steenberghe, D. Morphology of neural endings in the human periodontal ligament: An electron microscopic study. J. Periodontal Res. 1992, 27, 191–196.
Tabata, T.; Karita, K. Response properties of periodontal mechanosensitive fibers in the superior dental nerve of the cat. Exp. Neurol. 1986, 94, 469–478.
Karita, K.; Tabata, T. Response fields of the periodontal mechanosensitive units in the superior alveolar nerve of the cat. Exp. Neurol. 1985, 90, 558–565.
Tender, G.C.; Li, Y.-Y.; Cui, J.-G. Vanilloid receptor 1-positive neurons mediate thermal hyperalgesia and tactile allodynia. Spine J. 2008, 8, 351–358.
Christine, W.; Michael, G.H. Neuroanatomy, Touch Receptor; StatPearls Publishing: St. Petersburg, FL, USA, 2023.
Mengel, M.K.C.; Jyväsjärvi, E.; Kniffki, K.-D. Identification and characterization of afferent periodontal C fibres in the cat. PAIN 1992, 48, 413–420.
Bender, I.B. Pulpal Pain Diagnosis—A Review. J. Endod. 2000, 26, 175–179.
Toledo Mauriño, J.J.; Fonseca-Camarillo, G.; Furuzawa-Carballeda, J.; Barreto-Zuñiga, R.; Martínez Benítez, B.; Granados, J.; Yamamoto-Furusho, J.K. TRPV Subfamily (TRPV2, TRPV3, TRPV4, TRPV5, and TRPV6) Gene and Protein Expression in Patients with Ulcerative Colitis. J. Immunol. Res. 2020, 2020, 2906845.
Jara-Oseguera, A.; Simon, A.S.; Rosenbaum, T. TRPV1: On the Road to Pain Relief. Curr. Mol. Pharmacol. 2008, 1, 255–269.
Samanta, A.; Hughes, T.E.T.; Moiseenkova-Bell, V.Y. Transient Receptor Potential (TRP) Channels. In Membrane Protein Complexes: Structure and Function; Harris, J.R., Boekema, E.J., Eds.; Springer: Singapore, 2018; pp. 141–165.
Zygmunt, P.M.; Högestätt, E.D. TRPA1. In Mammalian Transient Receptor Potential (TRP) Cation Channels: Volume I; Nilius, B., Flockerzi, V., Eds.; Springer: Berlin/Heidelberg, Germany, 2014; pp. 583–630.
Cao, E.; Liao, M.; Cheng, Y.; Julius, D. TRPV1 structures in distinct conformations reveal activation mechanisms. Nature 2013, 504, 113–118.
Liao, M.; Cao, E.; Julius, D.; Cheng, Y. Structure of the TRPV1 ion channel determined by electron cryo-microscopy. Nature 2013, 504, 107–112.
Helley, M.P.; Abate, W.; Jackson, S.K.; Bennett, J.H.; Thompson, S.W.N. The expression of Toll-like receptor 4, 7 and co-receptors in neurochemical sub-populations of rat trigeminal ganglion sensory neurons. Neuroscience 2015, 310, 686–698.
Wadachi, R.; Hargreaves, K. Trigeminal nociceptors express TLR-4 and CD14: A mechanism for pain due to infection. J. Dent. Res. 2006, 85, 49–53.
Diogenes, A.; Ferraz, C.C.R.; Akopian, A.N.; Henry, M.A.; Hargreaves, K.M. LPS Sensitizes TRPV1 via Activation of TLR4 in Trigeminal Sensory Neurons. J. Dent. Res. 2011, 90, 759–764.
Meseguer, V.; Alpizar, Y.A.; Luis, E.; Tajada, S.; Denlinger, B.; Fajardo, O.; Manenschijn, J.-A.; Fernández-Peña, C.; Talavera, A.; Kichko, T.; et al. TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins. Nat. Commun. 2014, 5, 3125.
Ferraz, C.C.R.; Henry, M.A.; Hargreaves, K.M.; Diogenes, A. Lipopolysaccharide From Porphyromonas gingivalis Sensitizes Capsaicin-Sensitive Nociceptors. J. Endod. 2011, 37, 45–48.
Amara, S.G.; Jonas, V.; Rosenfeld, M.G.; Ong, E.S.; Evans, R.M. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 1982, 298, 240–244.
Fisher, L.A.; Kikkawa, D.O.; Rivier, J.E.; Amara, S.G.; Evans, R.M.; Rosenfeld, M.G.; Vale, W.W.; Brown, M.R. Stimulation of noradrenergic sympathetic outflow by calcitonin gene-related peptide. Nature 1983, 305, 534–536.
Russell, F.A.; King, R.; Smillie, S.-J.; Kodji, X.; Brain, S.D. Calcitonin Gene-Related Peptide: Physiology and Pathophysiology. Physiol. Rev. 2014, 94, 1099–1142.
v. Euler, U.S.; Gaddum, J.H. An unidentified depressor substance in certain tissue extracts. J. Physiol. 1931, 72, 74–87.
Krause, J.E.; Takeda, Y.; Hershey, A.D. Structure, Functions, and Mechanisms of Substance P Receptor Action. J. Investig. Dermatol. 1992, 98, S2–S7.
Mashaghi, A.; Marmalidou, A.; Tehrani, M.; Grace, P.M.; Pothoulakis, C.; Dana, R. Neuropeptide substance P and the immune response. Cell. Mol. Life Sci. 2016, 73, 4249–4264.
Arslan, H.; Yıldız, E.D.; Köseoğlu, S. Effects of endodontic treatment on salivary levels of CGRP and substance P: A pilot study. Restor. Dent. Endod. 2020, 45, e40.
Wakisaka, S. Neuropeptides in the dental pulp: Distribution, origins, and correlation. J. Endod. 1990, 16, 67–69.
Caviedes-Bucheli, J.; Muñoz, H.R.; Azuero-Holguín, M.M.; Ulate, E. Neuropeptides in Dental Pulp: The Silent Protagonists. J. Endod. 2008, 34, 773–788.
Kato, J.; Wakisaka, S.; Kurisu, K. Immunohistochemical Changes in the Distribution of Nerve Fibers in the Periodontal Ligament during an Experimental Tooth Movement of the Rat Molar. Acta Anat. 2008, 157, 53–62.
Caviedes-Bucheli, J.; Castellanos, F.; Vasquez, N.; Ulate, E.; Munoz, H.R. The influence of two reciprocating single-file and two rotary-file systems on the apical extrusion of debris and its biological relationship with symptomatic apical periodontitis. A systematic review and meta-analysis. Int. Endod. J. 2016, 49, 255–270.
Pradeep, A.R.; Raj, S.; Aruna, G.; Chowdhry, S. Gingival crevicular fluid and plasma levels of neuropeptide Substance-P in periodontal health, disease and after nonsurgical therapy. J. Periodontal Res. 2009, 44, 232–237.
Lundy, F.T.; Mullally, B.H.; Burden, D.J.; Lamey, P.-J.; Shaw, C.; Linden, G.J. Changes in substance P and neurokinin A in gingival crevicular fluid in response to periodontal treatment. J. Clin. Periodontol. 2000, 27, 526–530.
Burgener, B.; Ford, A.R.; Situ, H.; Fayad, M.I.; Hao, J.J.; Wenckus, C.S.; Johnson, B.R.; BeGole, E.A.; George, A. Biologic Markers for Odontogenic Periradicular Periodontitis. J. Endod. 2010, 36, 1307–1310.
Sacerdote, P.; Levrini, L. Peripheral Mechanisms of Dental Pain: The Role of Substance P. Mediat. Inflamm. 2012, 2012, 951920.
Takahashi, N.; Matsuda, Y.; Sato, K.; de Jong, P.R.; Bertin, S.; Tabeta, K.; Yamazaki, K. Neuronal TRPV1 activation regulates alveolar bone resorption by suppressing osteoclastogenesis via CGRP. Sci. Rep. 2016, 6, 29294.
Stashenko, P.; Teles, R.; d’Souza, R. Periapical inflammatory responses and their modulation. Crit. Rev. Oral Biol. Med. 1998, 9, 498–521.
Kim, S.; Dorscher-Kim, J. Effects of Substance P on Blood Flow of the Dental Pulp in Dogs. In Proceedings of the Substance P and Neurokinins; Springer-Verlag New York Inc.: New York, NY, USA, 1987; pp. 197–199.
Takeda, K.; Akira, S. Toll-Like Receptors. Curr. Protoc. Immunol. 2007, 77, 14.12.11–14.12.13.
Ma, W.; Dumont, Y.; Vercauteren, F.; Quirion, R. Lipopolysaccharide induces calcitonin gene-related peptide in the RAW264. 7 macrophage cell line. Immunology 2010, 130, 399–409.
Lai, J.-P.; Ho, W.Z.; Kilpatrick, L.E.; Wang, X.; Tuluc, F.; Korchak, H.M.; Douglas, S.D. Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation. Proc. Natl. Acad. Sci. USA 2006, 103, 7771–7776.
Marriott, I.; Bost, K.L. IL-4 and IFN-γ Up-Regulate Substance P Receptor Expression in Murine Peritoneal Macrophages1. J. Immunol. 2000, 165, 182–191.
Simeonidis, S.; Castagliuolo, I.; Pan, A.; Liu, J.; Wang, C.-C.; Mykoniatis, A.; Pasha, A.; Valenick, L.; Sougioultzis, S.; Zhao, D.; et al. Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-κB site on its promoter. Proc. Natl. Acad. Sci. USA 2003, 100, 2957–2962.
Goldman, R.; Bar-Shavit, Z.; Shezen, E.; Terry, S.; Blumberg, S. Enhancement of Phagocytosis by Neurotensin, a Newly Found Biological Activity of the Neuropeptide. In Macrophages and Natural Killer Cells: Regulation and Function; Normann, S.J., Sorkin, E., Eds.; Springer US: Boston, MA, USA, 1982; pp. 133–141.
Hartung, H.-P. Activation of macrophages by neuropeptides. Brain Behav. Immun. 1988, 2, 275–281.
Ruff, M.R.; Wahl, S.M.; Pert, C.B. Substance P receptor-mediated chemotaxis of human monocytes. Peptides 1985, 6, 107–111.
Hartung, H.-P.; Toyka, K.V. Substance P, the Immune System and Inflammation. Int. Rev. Immunol. 1989, 4, 229–249.
Cozens, P.J.; Rowe, F.M. Substance-P is a potent inducer of tnf and IL-1 secretion by macrophages—A potential role for tnf in the pathogenesis of asthma. Immunobiology 1987, 175, 7.
Saito, I.; Ishii, K.; Hanada, K.; Sato, O.; Maeda, T. Responses of calcitonin gene-related peptide-immunopositive nerve fibres in the periodontal ligament of rat molars to experimental tooth movement. Arch. Oral Biol. 1991, 36, 689–692.
Wakisaka, S.; Nishikawa, S.; Ichikawa, H.; Matsuo, S.; Takano, Y.; Akai, M. The distribution and origin of substance P-like immunoreactivity in the rat molar pulp and periodontal tissues. Arch. Oral Biol. 1985, 30, 813–818.
Heyeraas, K.J.; Kvinnsland, I.; Byers, M.R.; Jacobsen, E.B. Nerve fibers immunoreactive to protein gene product 9.5, calcitonin gene-related peptide, substance P, and neuropeptide Y in the dental pulp, periodontal ligament, and gingiva in cats. Acta Odontol. Scand. 1993, 51, 207–221.
Gašperšič, R.; Kovačič, U.; Cör, A.; Skalerič, U. Unilateral ligature-induced periodontitis influences the expression of neuropeptides in the ipsilateral and contralateral trigeminal ganglion in rats. Arch. Oral Biol. 2008, 53, 659–665.
Kabashima, H.; Nagata, K.; Maeda, K.; Iijima, T. Involvement of substance P, mast cells, TNF-α and ICAM-1 in the infiltration of inflammatory cells in human periapical granulomas. J. Oral Pathol. Med. 2002, 31, 175–180.
de Avila, E.D.; de Molon, R.S.; de Godoi Gonçalves, D.A.; Camparis, C.M. Relationship between levels of neuropeptide Substance P in periodontal disease and chronic pain: A literature review. J. Investig. Clin. Dent. 2014, 5, 91–97.
Ferrin, J.; Kirakodu, S.; Jensen, D.; Al-Attar, A.; Peyyala, R.; Novak, M.J.; Dawson, D.; Al-Sabbagh, M.; Stromberg, A.J.; Orraca, L.; et al. Gene expression analysis of neuropeptides in oral mucosa during periodontal disease in non-human primates. J. Periodontol. 2018, 89, 858–866.
Owan, I.; Ibaraki, K. The role of calcitonin gene-related peptide (CGRP) in macrophages: The presence of functional receptors and effects on proliferation and differentiation into osteoclast-like cells. Bone Miner. 1994, 24, 151–164.
Fernandez, S.; Knopf, M.A.; Bjork, S.K.; McGillis, J.P. Bone Marrow-Derived Macrophages Express Functional CGRP Receptors and Respond to CGRP by Increasing Transcription of c-fos and IL-6 mRNA. Cell. Immunol. 2001, 209, 140–148.
Ma, W.; Quirion, R. Increased calcitonin gene-related peptide in neuroma and invading macrophages is involved in the up-regulation of interleukin-6 and thermal hyperalgesia in a rat model of mononeuropathy. J. Neurochem. 2006, 98, 180–192.
Frielingsdorf, H.; Simpson, D.R.; Thal, L.J.; Pizzo, D.P. Nerve growth factor promotes survival of new neurons in the adult hippocampus. Neurobiol. Dis. 2007, 26, 47–55.
Ulupinar, E.; Jacquin, M.F.; Erzurumlu, R.S. Differential effects of NGF and NT-3 on embryonic trigeminal axon growth patterns. J. Comp. Neurol. 2000, 425, 202–218.
Minnone, G.; De Benedetti, F.; Bracci-Laudiero, L. NGF and Its Receptors in the Regulation of Inflammatory Response. Int. J. Mol. Sci. 2017, 18, 1028.
Salio, C.; Averill, S.; Priestley, J.V.; Merighi, A. Costorage of BDNF and neuropeptides within individual dense-core vesicles in central and peripheral neurons. Dev. Neurobiol. 2007, 67, 326–338.
Ehrhard, P.B.; Ganter, U.; Stalder, A.; Bauer, J.; Otten, U. Expression of functional trk protooncogene in human monocytes. Proc. Natl. Acad. Sci. USA 1993, 90, 5423–5427.
Sun, J.; Ramnath, R.D.; Zhi, L.; Tamizhselvi, R.; Bhatia, M. Substance P enhances NF-κB transactivation and chemokine response in murine macrophages via ERK1/2 and p38 MAPK signaling pathways. Am. J. Physiol. Cell Physiol. 2008, 294, C1586–C1596.
Lee, S.-K.; Pi, S.-H.; Kim, S.-H.; Min, K.-S.; Lee, H.-J.; Chang, H.-S.; Kang, K.-H.; Kim, H.-R.; Shin, H.-I.; Kim, E.-C. Substance P regulates macrophage inflammatory protein 3α/chemokine C-C ligand 20 (CCL20) with heme oxygenase-1 in human periodontal ligament cells. Clin. Exp. Immunol. 2007, 150, 567–575.
Keane, M.P.; Strieter, R.M.; Belperio, J.A. Macrophage inflammatory protein. In Encyclopedia of Respiratory Medicine; Laurent, G.J., Shapiro, S.D., Eds.; Academic Press: Oxford, UK, 2006; pp. 1–5.
Deshmane, S.L.; Kremlev, S.; Amini, S.; Sawaya, B.E. Monocyte Chemoattractant Protein-1 (MCP-1): An Overview. J. Interferon Cytokine Res. 2009, 29, 313–326.
Jiang, M.H.; Chung, E.; Chi, G.F.; Ahn, W.; Lim, J.E.; Hong, H.S.; Kim, D.W.; Choi, H.; Kim, J.; Son, Y. Substance P induces M2-type macrophages after spinal cord injury. Neuroreport 2012, 23, 786–792.
Hong, H.S.; Son, Y. Substance P ameliorates collagen II-induced arthritis in mice via suppression of the inflammatory response. Biochem. Biophys. Res. Commun. 2014, 453, 179–184.
Pinho-Ribeiro, F.A.; Verri, W.A.; Chiu, I.M. Nociceptor Sensory Neuron–Immune Interactions in Pain and Inflammation. Trends Immunol. 2017, 38, 5–19.
Rechenberg, D.K.; Munir, A.; Zehnder, M. Correlation between the clinically diagnosed inflammatory process and periapical index scores in severely painful endodontically involved teeth. Int. Endod. J. 2021, 54, 172–180.
Wideman, T.H.; Edwards, R.R.; Walton, D.M.; Martel, M.O.; Hudon, A.; Seminowicz, D.A. The Multimodal Assessment Model of Pain: A Novel Framework for Further Integrating the Subjective Pain Experience Within Research and Practice. Clin. J. Pain 2019, 35, 212.
Wilcox, C.E.; Mayer, A.R.; Teshiba, T.M.; Ling, J.; Smith, B.W.; Wilcox, G.L.; Mullins, P.G. The Subjective Experience of Pain: An FMRI Study of Percept-Related Models and Functional Connectivity. Pain Med. 2015, 16, 2121–2133.
Tarnawski, L.; Olofsson, P.S. Inflammation neuroscience: Neuro-immune crosstalk and interfaces. Clin. Transl. Immunol. 2021, 10, e1352.

© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.

Upload a video for this entry

Information

Subjects: Biochemistry & Molecular Biology

Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :

Nandita Menon

Anil Kishen

View Times: 236

Update Date: 15 Sep 2023

Table of Contents

Video Upload Options

Confirm